Thomas M. Ross - 29 Jul 2021 Form 3 Insider Report for MAXCYTE, INC. (MXCT)

Reporting relationship
EVP, Global Sales
Issuer ticker
MXCT
Reported as of
29 Jul 2021
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
29 Jul 2021, 18:44:15 UTC
Next SEC filing
11 Aug 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason Minio, Attorney-in-Fact

Key filing fact

Thomas M. Ross filed Form 3 for MAXCYTE, INC. (MXCT) on 29 Jul 2021.

Key facts

  • This page summarizes Thomas M. Ross's Form 3 filing for MAXCYTE, INC. (MXCT).
  • 0 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 29 Jul 2021, 18:44.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MXCT holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
182,105
Exercise price
$0.8400
Footnotes
F1
MXCT holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
62,000
Exercise price
$1.12
Footnotes
F1, F2
MXCT holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
75,000
Exercise price
$3.33
Footnotes
F1, F2
MXCT holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
75,000
Exercise price
$3.34
Footnotes
F2, F3
MXCT holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
98,800
Exercise price
$2.44
Footnotes
F2, F4
MXCT holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$1.87
Footnotes
F2, F5
MXCT holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$14.30
Footnotes
F2, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

This option is fully vested and exercisable.

Footnote F2

This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of GBP 1.00 to $1.3749 as of July 23, 2021.

Footnote F3

The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on August 18, 2018, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Footnote F4

The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Footnote F5

The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on February 20, 2020, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Footnote F6

Twenty-five percent (25%) of the shares underlying this option shall vest on January 13, 2022, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .